Works matching AU Chanan‐Khan, Asher


Results: 121
    1

    Trends in multiple myeloma presentation, management, cost of care, and outcomes in the Medicare population: A comprehensive look at racial disparities.

    Published in:
    2018
    By:
    • Ailawadhi, Sikander;
    • Frank, Ryan D.;
    • Sharma, Mayank;
    • Menghani, Richa;
    • Temkit, M'hamed;
    • Paulus, Shumail;
    • Khera, Nandita;
    • Hashmi, Shahrukh;
    • Advani, Pooja;
    • Swaika, Abhisek;
    • Paulus, Aneel;
    • Aslam, Nabeel;
    • Sher, Taimur;
    • Roy, Vivek;
    • Colon‐Otero, Gerardo;
    • Chanan‐Khan, Asher;
    • Temkit, M'hamed;
    • Colon-Otero, Gerardo;
    • Chanan-Khan, Asher
    Publication type:
    journal article
    2
    3
    4
    5
    6
    8

    Arterial thrombosis in four patients treated with thalidomide.

    Published in:
    Leukemia & Lymphoma, 2005, v. 46, n. 2, p. 239, doi. 10.1080/10428190400015675
    By:
    • Scarpace, Sarah L.;
    • Hahn, Theresa;
    • Roy, Hilary;
    • Brown, Karen;
    • Paplham, Pamela;
    • Chanan-Khan, Asher;
    • van Besien, Koen;
    • McCarthy, Jr, Philip L.
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23

    Real world outcomes with elotuzumab-based therapies for patients with relapsed refractory multiple myeloma: a Mayo Clinic experience.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01310-z
    By:
    • Parrondo, Ricardo D.;
    • Das, Saurav;
    • Sledge, Hanna;
    • Bergsagel, Leif;
    • Fonseca, Rafael;
    • Leung, Nelson;
    • Kapoor, Prashant;
    • Gertz, Morie;
    • Buadi, Francis;
    • Dispenzieri, Angela;
    • Elliott, Jamie;
    • Fernandez, Andre;
    • Flott, Caitlin;
    • Chanan-Khan, Asher A.;
    • Roy, Vivek;
    • Ailawadhi, Sikander
    Publication type:
    Article
    24
    25

    CLL-115: First Results of a Head-to-Head Trial of Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S318, doi. 10.1016/S2152-2650(21)01750-X
    By:
    • Byrd, John C.;
    • Hillmen, Peter;
    • Ghia, Paolo;
    • Kater, Arnon P.;
    • Chanan-Khan, Asher;
    • Furman, Richard R.;
    • O'Brien, Susan;
    • Yenerel, Mustafa Nuri;
    • Illes, Arpad;
    • Kay, Neil;
    • Garcia-Marco, Jose A.;
    • Mato, Anthony;
    • Pinilla-Ibarz, Javier;
    • Seymour, John F.;
    • Lepretre, Stephane;
    • Stilgenbauer, Stephan;
    • Robak, Tadeusz;
    • Patel, Priti;
    • Higgins, Kara;
    • Sohoni, Sophia
    Publication type:
    Article
    26

    Poster: CLL-115: First Results of a Head-to-Head Trial of Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S220, doi. 10.1016/S2152-2650(21)01389-6
    By:
    • Byrd, John C.;
    • Hillmen, Peter;
    • Ghia, Paolo;
    • Kater, Arnon P.;
    • Chanan-Khan, Asher;
    • Furman, Richard R.;
    • O'Brien, Susan;
    • Yenerel, Mustafa Nuri;
    • Illes, Arpad;
    • Kay, Neil;
    • Garcia-Marco, Jose A.;
    • Mato, Anthony;
    • Pinilla-Ibarz, Javier;
    • Seymour, John F.;
    • Lepretre, Stephane;
    • Stilgenbauer, Stephan;
    • Robak, Tadeusz;
    • Patel, Priti;
    • Higgins, Kara;
    • Sohoni, Sophia
    Publication type:
    Article
    27

    Efficacy of Daratumumab-Based Regimens for the Treatment of Plasma Cell Leukemia.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 5, p. 355, doi. 10.1016/j.clml.2021.01.002
    By:
    • Parrondo, Ricardo D.;
    • Moustafa, Muhamad Alhaj;
    • Reeder, Craig;
    • Sher, Taimur;
    • Roy, Vivek;
    • Muchtar, Eli;
    • Warsame, Rahma;
    • Alegria, Victoria;
    • Gonsalves, Wilson;
    • Dingli, David;
    • Hayman, Suzanne;
    • Kapoor, Prashant;
    • Chanan-Khan, Asher A.;
    • Ailawadhi, Sikander
    Publication type:
    Article
    28

    Trends in Early Mortality From Multiple Myeloma: A Population-Based Analysis.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 5, p. e449, doi. 10.1016/j.clml.2020.12.023
    By:
    • Kumar, Vivek;
    • Ailawadhi, Meghna;
    • Dutta, Navnita;
    • Abdulazeez, Mays;
    • Aggarwal, Chander Shekher;
    • Quintero, Gerson;
    • Baksh, Mizba;
    • Roy, Vivek;
    • Taimur Sher;
    • Alegria, Victoria;
    • Paulus, Aneel;
    • Chanan-Khan, Asher;
    • Ailawadhi, Sikander
    Publication type:
    Article
    29

    Long-Term Studies Assessing Outcomes of Ibrutinib Therapy in Patients With Del(11q) Chronic Lymphocytic Leukemia.

    Published in:
    2019
    By:
    • Kipps, Thomas J.;
    • Fraser, Graeme;
    • Coutre, Steven E.;
    • Brown, Jennifer R.;
    • Barrientos, Jacqueline C.;
    • Barr, Paul M.;
    • Byrd, John C.;
    • O'Brien, Susan M.;
    • Dilhuydy, Marie-Sarah;
    • Hillmen, Peter;
    • Jaeger, Ulrich;
    • Moreno, Carol;
    • Cramer, Paula;
    • Stilgenbauer, Stephan;
    • Chanan-Khan, Asher A.;
    • Mahler, Michelle;
    • Salman, Mariya;
    • Eckert, Karl;
    • Solman, Isabelle G.;
    • Balasubramanian, Sriram
    Publication type:
    journal article
    30
    31
    32
    33

    A Phase 1b Study of Venetoclax Combined with Bortezomib and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e16, doi. 10.1016/j.clml.2017.03.027
    By:
    • Moreau, Philippe;
    • Chanan-Khan, Asher;
    • Roberts, Andrew W.;
    • Agarwal, Amit B.;
    • Facon, Thierry;
    • Kumar, Shaji;
    • Touzeau, Cyrille;
    • Cordero, Jaclyn;
    • Ross, Jeremy;
    • Munasinghe, Wijith;
    • Jia, Jia;
    • Salem, Ahmed H.;
    • Leverson, Joel;
    • Maciag, Paulo;
    • Verdugo, Maria;
    • Harrison, Simon J.
    Publication type:
    Article
    34
    35

    Daratumumab, Bortezomib and Dexamethasone (DVd) vs Bortezomib and Dexamethasone (Vd) in RRMM Based on Prior Lines and Treatment Exposure: CASTOR.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e133, doi. 10.1016/j.clml.2017.03.240
    By:
    • Lentzsch, Suzanne;
    • Nooka, Ajay;
    • Quach, Hang;
    • Lee, Cindy;
    • Barreto, Wolney;
    • Corradini, Paolo;
    • Min, Chang Ki;
    • Scott, Emma;
    • Chanan-Khan, Asher;
    • Horvath, Noemi;
    • Capra, Marcelo;
    • Beksac, Meral;
    • Ovilla, Roberto;
    • Jo, Jae-Cheol;
    • Shin, Ho-Jin;
    • Soong, David;
    • Casneuf, Tineke;
    • Chiu, Christopher;
    • Qin, Xiang;
    • Amin, Himal
    Publication type:
    Article
    36
    37
    38
    39
    40
    41

    Implementing individualized medicine into the medical practice.

    Published in:
    American Journal of Medical Genetics. Part C: Seminars in Medical Genetics, 2014, v. 166C, n. 1, p. 15, doi. 10.1002/ajmg.c.31387
    By:
    • Lazaridis, Konstantinos N.;
    • MCAllister, Tammy M.;
    • Babovic‐Vuksanovic, Dusica;
    • Beck, Scott A.;
    • Borad, Mitesh J.;
    • Bryce, Alan H.;
    • Chanan‐Khan, Asher A.;
    • Ferber, Matthew J.;
    • Fonseca, Rafael;
    • Johnson, Kiley J.;
    • Klee, Eric W.;
    • Lindor, Noralane M.;
    • MCCormick, Jennifer B.;
    • MCWilliams, Robert R.;
    • Parker, Alexander S.;
    • Riegert‐Johnson, Douglas L.;
    • Rohrer Vitek, Carolyn R.;
    • Schahl, Kimberly A.;
    • Schultz, Cloann;
    • Stewart, Keith
    Publication type:
    Article
    42
    43
    44

    AT-101 Enhances the Antitumor Activity of Lenalidomide in Patients with Multiple Myeloma.

    Published in:
    Cancers, 2023, v. 15, n. 2, p. 477, doi. 10.3390/cancers15020477
    By:
    • Ailawadhi, Sikander;
    • Parrondo, Ricardo D.;
    • Dutta, Navnita;
    • Han, Bing;
    • Ciccio, Gina;
    • Cherukuri, Yesesri;
    • Alegria, Victoria R.;
    • LaPlant, Betsy R.;
    • Roy, Vivek;
    • Sher, Taimur;
    • Edwards, Brett;
    • Lanier, Stephanie;
    • Manna, Alak;
    • Heslop, Keisha;
    • Caulfield, Thomas;
    • Maldosevic, Emir;
    • Storz, Peter;
    • Manochakian, Rami;
    • Asmann, Yan;
    • Chanan-Khan, Asher A.
    Publication type:
    Article
    45
    46

    The development of novel targeted therapeutics for treatment of multiple myeloma research roundtable.

    Published in:
    European Journal of Haematology, 2003, v. 70, n. 4, p. 263, doi. 10.1034/j.1600-0609.2003.t01-2-00011.x
    By:
    • Anderson, Kenneth C.;
    • Barlogie, Bart;
    • Berenson, James R.;
    • Dalton, William S.;
    • Adams, Julian;
    • Alsina, Melissa;
    • Bekker, Pirow;
    • Bergsagel, Peter L.;
    • Boise, Lawrence;
    • Chan, Kyle;
    • Chanan-Khan, Asher A.;
    • Comenzo, Raymond;
    • Congdon, Deborah;
    • Croucher, Peter;
    • Epstein, Joshua;
    • Fenton, Robert;
    • Fonseca, Rafael;
    • Gallant, Gilles;
    • Hussein, Mohamad A.;
    • Jagannath, Sundar
    Publication type:
    Article
    47

    Utilization of radiation therapy in multiple myeloma: trends and changes in practice.

    Published in:
    Annals of Hematology, 2021, v. 100, n. 3, p. 735, doi. 10.1007/s00277-020-04371-1
    By:
    • Ailawadhi, Sikander;
    • Frank, Ryan;
    • Ailawadhi, Meghna;
    • Kanji, Zahara;
    • Jani, Prachi;
    • Fiala, Mark;
    • Abdulazeez, Mays;
    • Ahmed, Salman;
    • Aggarwal, Chander Shekher;
    • Aulakh, Sonikpreet;
    • Hodge, David;
    • Roy, Vivek;
    • Alegria, Victoria R.;
    • Paulus, Aneel;
    • Chanan-Khan, Asher;
    • Sher, Taimur
    Publication type:
    Article
    48
    49

    Atrial fibrillation in patients with chronic lymphocytic leukemia (CLL) treated with ibrutinib: risk prediction, management, and clinical outcomes.

    Published in:
    Annals of Hematology, 2021, v. 100, n. 1, p. 143, doi. 10.1007/s00277-020-04094-3
    By:
    • Archibald, William J.;
    • Rabe, Kari G.;
    • Kabat, Brian F.;
    • Herrmann, Joerg;
    • Ding, Wei;
    • Kay, Neil E.;
    • Kenderian, Saad S.;
    • Muchtar, Eli;
    • Leis, Jose F.;
    • Wang, Yucai;
    • Chanan-Khan, Asher A.;
    • Schwager, Susan M.;
    • Koehler, Amber B.;
    • Fonder, Amie L.;
    • Slager, Susan L.;
    • Shanafelt, Tait D.;
    • Call, Timothy G.;
    • Parikh, Sameer A.
    Publication type:
    Article
    50